000 03545namaa2200625uu 4500
001 oapen54019
003 oapen
005 20231220173721.0
006 m o d
007 cr|mn|---annan
008 220413s2022 xx |||||o ||| 0|eng d
020 _a978-3-030-92612-0
020 _a9783030926120
024 7 _a10.1007/978-3-030-92612-0
_2doi
040 _aoapen
_coapen
041 0 _aeng
042 _adc
072 7 _aHP
_2bicssc
072 7 _aKCQ
_2bicssc
072 7 _aMBN
_2bicssc
072 7 _aMJCL
_2bicssc
072 7 _aPSAD
_2bicssc
100 1 _aBremer, Anne
_4edt
_91284906
245 1 0 _aPrecision Oncology and Cancer Biomarkers
_bIssues at Stake and Matters of Concern
260 _aCham
_bSpringer Nature
_c2022
300 _a1 electronic resource (281 p.)
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
490 1 _aHuman Perspectives in Health Sciences and Technology
_v5
506 0 _aOpen Access
_fUnrestricted online access
_2star
520 _aThis open access book reflects on matters of social and ethical concern raised in the daily practices of those working in and around precision oncology. Each chapter addresses the experiences, concerns and issues at stake for people who work in settings where precision oncology is practiced, enacted, imagined or discussed. It subsequently discusses and analyses bioethical dilemmas, scientific challenges and economic trade-offs, the need for new policies, further technological innovation, social work, as well as phenomenological research. This volume takes a broad actor-centred perspective as, whenever cancer is present, the range of actors with issues at stake appears almost unlimited. This perspective and approach opens up the possibility for further in-depth and diverse questions, posed by the actors themselves, such as: How are cancer researchers navigating biological uncertainties? How do clinicians and policy-makers address ethical dilemmas around prioritisation of care? What are the patients' experiences with, and hopes for, precision oncology? How do policy-makers and entrepreneurs envisage precision oncology? These questions are of great interest to a broad audience, including cancer researchers, oncologists, policy-makers, medical ethicists and philosophers, social scientists, patients and health economists.
540 _aCreative Commons
_fby/4.0/
_2cc
_uhttp://creativecommons.org/licenses/by/4.0/
546 _aEnglish
650 7 _aBio-ethics
_2bicssc
_9266
650 7 _aHealth economics
_2bicssc
650 7 _aOncology
_2bicssc
_969459
650 7 _aPhilosophy
_2bicssc
650 7 _aPublic health & preventive medicine
_2bicssc
_9923786
653 _acancer biomarkers
653 _ahealth technology assessment
653 _aOncology
653 _aOpen access
653 _apersonalised cancer treatments
653 _aPhilosophy of medicine
653 _aprecision oncology
653 _aScience and Technology Studies
653 _aSociology of medicine
700 1 _aBremer, Anne
_4oth
_91284906
700 1 _aStrand, Roger
_4edt
_91284907
700 1 _aStrand, Roger
_4oth
_91284907
793 0 _aOAPEN Library.
856 4 0 _uhttps://library.oapen.org/bitstream/id/99cfc909-5891-4714-b75c-b079ca12a294/978-3-030-92612-0.pdf
_70
_zOpen Access: OAPEN Library, download the publication
856 4 0 _uhttps://library.oapen.org/handle/20.500.12657/54019
_70
_zOpen Access: OAPEN Library: description of the publication
999 _c3073358
_d3073358